Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21663949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin
2 Completed
Has Results
Study of Heart and Renal Protection
Condition: Kidney Disease, Chronic
Interventions: Drug: Simvastatin 20 mg;   Drug: Ezetimibe 10mg;   Drug: Placebo

Indicates status has not been verified in more than two years